Stroke: Roles of B vitamins, homocysteine and antioxidants

Nutrition Research Reviews

Volumn 22, Issue 1, 2009, Pages 49-67

  Sánchez Moreno, Concepción ^a   Jiménez Escrig, Antonio ^a   Martín, Antonio ^b  

^a INSTITUTO DEL FRÍO CSIC   (Spain)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Antioxidant vitamins E and C; B vitamins; Homocysteine; Oxidative stress; Stroke

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; VITAMIN B GROUP; VITAMIN; VITAMIN B COMPLEX;

ATHEROSCLEROSIS; BRAIN ISCHEMIA; CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY DISEASE; CYANOCOBALAMIN DEFICIENCY; DEGENERATIVE DISEASE; DEMENTIA; DIETARY INTAKE; DRUG MECHANISM; DRUG MEGADOSE; ENDOTHELIUM INJURY; FOOD INTAKE; HEART INFARCTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; REVIEW; STROKE; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD; FRUIT; METABOLISM; VEGETABLE; VITAMIN DEFICIENCY;

ANTIOXIDANTS; AVITAMINOSIS; FRUIT; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; STROKE; VEGETABLES; VITAMIN B COMPLEX; VITAMINS;

EID: 69249209978     PISSN: 09544224     EISSN: 14752700     Source Type: Journal    
DOI: 10.1017/S0954422409990023     Document Type: Review

References (175)

1. Acheson RM & Williams DR (1983) Does consumption of fruit and vegetables protect against stroke? Lancet i, 1191-1193.
2. Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. (1998) Clinical determinants of poststroke dementia. Stroke 29, 75-81.
3. Kase CS,Wolf PA, Kelly-Hayes M, et al. (1998) Intellectual decline after stroke: the Framingham Study. Stroke 29, 805-812. (Pubitemid 28173406)
4. Henon H, Lebert F, Durieu I, et al. (1999) Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke 30, 773-779. (Pubitemid 29156367)
5. Patel MD, Coshall C, Rudd AG, et al. (2002) Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc 50, 700-706. (Pubitemid 34298758)
6. Gale CR, Martyn CN, Winter PD, et al. (1995) Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br Med J 310, 1563-1566.
7. Gale CR, Martyn CN & Cooper C (1996) Cognitive impairment and mortality in a cohort of elderly people. Br Med J 312, 608-611. (Pubitemid 26079596)
8. Gonzalez-Gross M, Marcos A & Pietrzik K (2001) Nutrition and cognitive impairment in the elderly. Br J Nutr 86, 313-321.
9. Singleton CK & Martin PR (2001) Molecular mechanisms of thiamine utilization. Curr Mol Med 1, 197-207.
10. Mesnard F, Roscher A, Garlick AP, et al. (2002) Evidence for the involvement of tetrahydrofolate in the demethylation of nicotine by Nicotiana plumbaginifolia cell-suspension cultures. Planta 214, 911-919. (Pubitemid 36059257)
11. Nilsson K, Gustafson L & Hultberg B (1999) Plasma homocysteine is a sensitive marker for tissue deficiency of both cobalamines and folates in a psychogeriatric population. Dement Geriatr Cogn Disord 10, 476-482. (Pubitemid 29512015)
12. Sarkar PK & Lambert LA (2001) Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke. Int J Clin Pract 55, 262-268. (Pubitemid 32514665)
13. Miller JW, Green R, Mungas DM, et al. (2002) Homocysteine, vitamin B6, and vascular disease in AD patients. Neurology 58, 1471-1475. (Pubitemid 34552951)
14. Rogers PJ (2001) A healthy body, a healthy mind: long-term impact of diet on mood and cognitive function. Proc Nutr Soc 60, 135-143.
15. Robinson K (2000) Homocysteine, B vitamins, and risk of cardiovascular disease. Heart 83, 127-130.
16. Wang HX, Wahlin A, Basun H, et al. (2001) Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56, 1188-1194. (Pubitemid 32405713)
17. Ascherio A, Rimm EB, Hernan MA, et al. (1999) Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Int Med 130, 963-970. (Pubitemid 29283986)
18. Leppälä JM, Virtamo J, Fogelholm R, et al. (2000)Vitamin E and β carotene supplementation in high risk for stroke: a subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Arch Neurol 57, 1503-1509.
19. Liu SM, Manson JE, Stampfer MJ, et al. (2000) Whole grain consumption and risk of ischemic stroke in women: a prospective study. JAMA 284, 1534-1540. (Pubitemid 30767442)
20. Ranjan A, Theodore D, Haran RP, et al. (1993) Ascorbic acid and focal cerebral ischaemia in a primate model. Acta Neurochir 123, 87-91. (Pubitemid 23240678)
21. Simon JA & Hudes ES (1999) Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults: the Third National Health and Nutrition Examination Survey (NHANES III). Ann Epidemiol 9, 358-365. (Pubitemid 29378346)
22. Feldman EB (2001) Fruits and vegetables and the risk of stroke. Nutr Rev 59, 24-27.
23. Gillman MW, Cupples AL, Gagnon D, et al. (1995) Protective effect of fruits and vegetables on development of stroke in men. JAMA 273, 1113-1117.
24. Yochum LA, Folsom AR & Kushi LH (2000) Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women. Am J Clin Nutr 72, 476-483. (Pubitemid 30620655)
25. Steiner M (1995) Vitamin E may enhance the benefits of aspirin in preventing stroke. Am Fam Physician 51, 1977.
26. Polasek J (1997) Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis. Can J Cardiol 13, 533-535. (Pubitemid 27246599)
27. Pryor WA (2000) Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 28, 141-164. (Pubitemid 30045582)
28. Lauber RP & Sheard NF (2001) The American Heart Association Dietary Guidelines for 2000: a summary report. Nutr Rev 59, 298-306. (Pubitemid 32879071)
29. Padro L, Benacer R, Foix S, et al. (2002) Assessment of dietary adequacy for an elderly population based on a Mediterranean model. J Nutr Health Aging 6, 31-33. (Pubitemid 35364168)
30. Klipstein-Grobusch K, den Breeijen JH, Grobbee DE, et al. (2001) Dietary antioxidants and peripheral arterial disease: the Rotterdam Study. Am J Epidemiol 154, 145-149. (Pubitemid 32643129)
31. Brussaard JH, Löwik MR, van den Berg H, et al. (1997) Folate intake and status among adults in the Netherlands. Eur J Clin Nutr 51, S46-S50.
32. de Bree A, Verschuren WMM, Blom HJ, et al. (2001) Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr 73, 1027-1033.
33. Kelly PJ & Furie KL (2002) Management and prevention of stroke associated with elevated homocysteine. Curr Treat Options Cardiovasc Med 4, 363-371.
34. Liaugaudas G, Jacques PF, Selhub J, et al. (2001) Renal insufficiency, vitamin B12 status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour. Arterioscler Thromb Vasc Biol 21, 849-851. (Pubitemid 32448778)
35. Green R & Miller JW (2005) Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med 43, 1048-1051. (Pubitemid 41581959)
36. Howard VJ, Sides EG, Newman GC, et al. (2002) Changes in plasma homocyst(e)ine in the acute phase after stroke. Stroke 33, 473-478. (Pubitemid 34123390)
37. Mezzano D, Pais EO, Aranda E, et al. (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60, 1844-1850. (Pubitemid 32999989)
38. Strazzullo P, Scalfi L, Branca E, et al. (2004) Nutrition and prevention of ischemic stroke: present knowledge, limitations and future perspectives. Nutr Metab Cardiovasc Dis 14, 97-114. (Pubitemid 38813711)
39. Spence JD (2003) Nutritional and metabolic aspects of stroke prevention. Adv Neurol 92, 173-178.
40. Gariballa SE (2000) Nutritional factors in stroke. Br J Nutr 84, 5-17.
41. Gariballa SE (2000) Nutritional support in elderly patients. J Nutr Health Aging 4, 25-27.
42. Renaud SC (2001) Diet and stroke. J Nutr Health Aging 5, 167-172.
43. Gariballa SE, Parker SG, Taub N, et al. (1998) Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 68, 275-281. (Pubitemid 28355643)
44. Gariballa SE, Parker SG, Taub N, et al. (1998) Nutritional status of hospitalized acute stroke patients. Br J Nutr 79, 481-487. (Pubitemid 28356629)
45. Elmståhl S, Bülow M, Ekberg O, et al. (1999) Treatment of dysphagia improves nutritional conditions in stroke patients. Dysphagia 14, 61-66.
46. Dennis M (2000) Nutrition after stroke. Br Med Bull 56, 466-475.
47. Westergren A, Karlsson S, Andersson P, et al. (2001) Eating difficulties, need for assisted eating, nutritional status and pressure ulcers in patients admitted for stroke rehabilitation. J Clin Nurs 10, 257-269.
48. Westergren A, Ohlsson O & Hallberg IR (2001) Eating difficulties, complications and nursing interventions during a period of three months after a stroke. J Adv Nurs 35, 416-426. (Pubitemid 33603267)
49. Deschamps V, Barberger-Gateau P, Peuchant E, et al. (2001) Nutritional factors in cerebral aging and dementia: epidemiological arguments for a role of oxidative stress. Neuroepidemiology 20, 7-15. (Pubitemid 32171133)
50. Spence JD (2006) Nutrition and stroke prevention. Stroke 37, 2430-2435.
51. Van Duyn MA & Pivonka E (2000) Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature. J Am Diet Assoc 100, 1511-1521.
52. Bazzano LA, He J, Ogden LG, et al. (2002) Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am J Clin Nutr 76, 93-99. (Pubitemid 34686554)
53. Gillman MW, Cupples LA, Millen BE, et al. (1997) Inverse association of dietary fat with development of ischemic stroke in men. JAMA 278, 2145-2150.
54. Iso H, Rexrode KM, Stampfer MJ, et al. (2001) Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 285, 304-312. (Pubitemid 32095033)
55. Zhang J, Sasaki S, Amano K, et al. (1999) Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med 28, 520-529. (Pubitemid 29370288)
56. Molloy AM, Mills JL, Kirke PN, et al. (1999) Folate status and neural tube defects. Biofactors 10, 291-294. (Pubitemid 29533843)
57. Selhub J, Bagley LC, Miller J, et al. (2000) B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 71, 614S-620S. (Pubitemid 30061246)
58. Rosenberg IH (2001) B vitamins, homocysteine, and neurocognitive function. Nutr Rev 59, S69-S73.
59. Balk EM, Raman G, Tatsioni A, et al. (2007) Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 167, 21-30.
60. Robinson K, Arheart K, Refsum H, et al. (1998) Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. Circulation 97, 437-443. (Pubitemid 28090214)
61. Troen A & Rosenberg I (2005) Homocysteine and cognitive function. Semin Vasc Med 5, 209-214.
62. Clarke R (2008) B vitamins and prevention of dementia. Proc Nutr Soc 67, 75-81.
63. Bazzano LA, He J, Ogden LG, et al. (2002) Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke 33, 1183-1189. (Pubitemid 34517031)
64. Albert CM, Cook NR, Gaziano JM, et al. (2008) Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 299, 2027-2036.
65. Lonn E, Yusuf S, Arnold MJ, et al. (2006) Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354, 1567-1577.
66. Bønaa KH, Njølstad I, Ueland PM, et al. (2006) Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354, 1578-1588.
67. Beamer NB, Coull BM, Press RD, et al. (1999) Vitamin use in patients with ischemic stroke. Neurology 52, A64.
68. VITATOPS Trial Study Group (2002) The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis 13, 120-126.
69. Spence JD, Howard VJ, Chambless LE, et al. (2001) Vitamin Intervention for Stroke Prevention (VISP) Trial: rationale and design. Neuroepidemiology 20, 16-25.
70. Toole JF, Malinow MR, Chambless LE, et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565-575.
71. Hankey GJ & Eikelboom JW (2004) Folic acid-based multivitamin therapy to prevent stroke: the jury is still out. Stroke 35, 1995-1998.
72. Wald DS, Law M & Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325, 1202-1208. (Pubitemid 35398783)
73. He K, Merchant A, Rimm EB, et al. (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35, 169-174.
74. Clarke R & Armitage J (2000) Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost 26, 341-348. (Pubitemid 30703459)
75. Yang Q, Botto LD, Erickson JD, et al. (2006) Improvement in stroke mortality in Canada and the United States, 1990 to 2002. Circulation 113, 1335-1343. (Pubitemid 43739455)
76. Goldstein LB (2000) Novel risk factors for stroke: homocysteine, inflammation, and infection. Curr Atheroscler Rep 2, 110-114.
77. Perry IJ (1999) Homocysteine, hypertension and stroke. J Hum Hypertens 13, 289-293.
78. Perry IJ (1999) Homocysteine and risk of stroke. J Cardiovasc Risk 6, 235-240.
79. Hankey GJ (2002) Is homocysteine a causal and treatable risk factor for vascular diseases of the brain (cognitive impairment and stroke)? Ann Neurol 51, 279-281.
80. Christopher R, Nagaraja D & Shankar SK (2007) Homocysteine and cerebral stroke in developing countries. Curr Med Chem 14, 2393-2401. (Pubitemid 47618047)
81. McNulty H, Pentieva K, Hoey L, et al. (2008) Homocysteine, B vitamins and CVD. Proc Nutr Soc 67, 232-237.
82. Cui RZ, Moriyama Y, Koike KA, et al. (2008) Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: the JACC study. Atherosclerosis 198, 412-418.
83. Ntaios GC, Savopoulos CG, Chatzinikolaou AC, et al. (2008) Vitamins and stroke: the homocysteine hypothesis still in doubt. Neurologist 14, 2-4.
84. Clarke R, Armitage J, Lewington S, et al. (2007) Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis. Clin Chem Lab Med 45, 1575-1581. (Pubitemid 350232974)
85. Carlsson CM (2007) Lowering homocysteine for stroke prevention. Lancet 369, 1841-1842.
86. Spence JD (2006) Homocysteine and stroke prevention: have the trials settled the issue? Int J Stroke 1, 242-244.
87. Loscalzo J (2006) Homocysteine trials - clear outcomes for complex reasons. N Engl J Med 354, 1629-1632.
88. Herrmann W (2001) The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 39, 666-674. (Pubitemid 32894409)
89. Morris MS, Jacques PF, Rosenberg IH, et al. (2000) Serum total homocysteine concentration is related to self-reported heart attack or stroke history among men and women in the NHANES III. J Nutr 130, 3073-3076.
90. Kuller LH & Evans RW (1998) Homocysteine, vitamins, and cardiovascular disease. Circulation 98, 196-199.
91. Giles WH, Croft JB, Greenlund KJ, et al. (1998) Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Stroke 29, 2473-2477. (Pubitemid 28543992)
92. Perry IJ, Refsum H, Morris RW, et al. (1995) Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346, 1395-1398.
93. Verhoef P, Hennekens CH, Malinow MR, et al. (1994) A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke 25, 1924-1930. (Pubitemid 24291274)
94. Fallon UB, Elwood P, Ben-Shlomo Y, et al. (2001) Homocysteine and ischaemic stroke in men: the Caerphilly study. J Epidemiol Community Health 55, 91-96. (Pubitemid 32095194)
95. Bots ML, Launer LJ, Lindemans J, et al. (1999) Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159, 38-44. (Pubitemid 29044117)
96. Fridman O (1999) Hyperhomocysteinemia: atherothrombosis and neurotoxicity. Acta Physiol Pharmacol Ther Latinoam 49, 21-30.
97. Mayer EL, Jacobsen DW & Robinson K (1996) Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 27, 517-527.
98. Mutus B, Rabini RA, Staffolani R, et al. (2001) Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects. Diabetologia 44, 979-982. (Pubitemid 32778129)
99. Durand P, Lussier-Cacan S & Blache D (1997) Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 11, 1157-1168. (Pubitemid 27481440)
100. Prasad K (1999) Homocysteine, a risk factor for cardiovascular disease. Int J Angiology 8, 76-86. (Pubitemid 29057913)
101. Coppola A, Davi G, De Stefano V, et al. (2000) Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26, 243-254. (Pubitemid 30703449)
102. Zhang G, Zhao H & Zhang L (1999) Effects of homocysteine on human vascular endothelial cells, platelet aggregation and heparin cofactor activity (article in Chinese). Zhonghua Xue Ye Xue Za Zhi 20, 471-473.
103. Hladovec J, Sommerova Z & Pisarikova A (1997) Homocysteinemia and endothelial damage after methionine load. Thromb Res 88, 361-364. (Pubitemid 28131525)
104. Domagala TB, Undas A, Libura M, et al. (1998) Pathogenesis of vascular disease in hyperhomocysteinaemia. J Cardiovasc Risk 5, 239-247.
105. Zhang C, Cai Y, Adachi MT, et al. (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response. J Biol Chem 276, 35867-35874. (Pubitemid 37384393)
106. Mercié P, Garnier O, Lascoste L, et al. (2000) Homocysteine-thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 5, 403-411. (Pubitemid 32162622)
107. Wang H, Yoshizumi M, Lai KH, et al. (1997) Inhibition of growth and p21ras methylation in vascular endothelial cells by homocysteine but not cysteine. J Biol Chem 272, 25380-25385. (Pubitemid 27415732)
108. Chambers JC, McGregor A, Jean-Marie J, et al. (1999) Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99, 1156-1160. (Pubitemid 29120086)
109. Li H, Lewis A, Brodsky S, et al. (2002) Homocysteine induces 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells: a mechanism for development of atherosclerosis? Circulation 105, 1037-1043.
110. Kokame K, Kato H & Miyata T (1998) Nonradioactive differential display cloning of genes induced by homocysteine in vascular endothelial cells. Methods 16, 434-443. (Pubitemid 128680909)
111. SoRelle R (2002) Inflammation-sensitive proteins: another ingredient in stroke? Circulation 105, e9111.
112. Outinen PA, Sood SK, Pfeifer SI, et al. (1999) Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 94, 959-967.
113. Cai Y, Zhang C, Nawa T, et al. (2000) Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood 96, 2140-2148. (Pubitemid 30696243)
114. Poddar R, Sivasubramanian N, DiBello PM, et al. (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103, 2717-2723. (Pubitemid 32538788)
115. Holven KB, Aukrust P, Holm T, et al. (2002) Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol 22, 699-703. (Pubitemid 34408756)
116. Wang G, Siow YL & O K (2001) Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-κB in THP-1 macrophages. Am J Physiol Heart Circ Physiol 280, H2840-H2847.
117. Desai A, Lankford HA & Warren JS (2001) Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 25, 179-186. (Pubitemid 32493691)
118. Roth J, Goebeler M, Ludwig S, et al. (2001) Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-κB activity. Biochim Biophys Acta 1540, 154-165. (Pubitemid 32763157)
119. Cherubini A, Ruggiero C, Morand C, et al. (2008) Dietary antioxidants as potential pharmacological agents for ischemic stroke. Curr Med Chem 15, 1236-1248. (Pubitemid 351997810)
120. Moats C & Rimm EB (2007) Vitamin intake and risk of coronary disease: observation versus intervention. Curr Atheroscler Rep 9, 508-514.
121. Thomas DR (2006) Vitamins in aging, health, and longevity. Clin Intervent Aging 1, 81-91.
122. Arria AM, Tarter RE, Warty V, et al. (1990) Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Am J Clin Nutr 52, 383-390. (Pubitemid 20227840)
123. Shorer Z, Parvari R, Bril G, et al. (1996) Ataxia with isolated vitamin E deficiency in four siblings. Pediatr Neurol 15, 340-343. (Pubitemid 26418936)
124. Behl C (1999) Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res 69, 213-219.
125. Launer LJ & Kalmijn S (1998) Anti-oxidants and cognitive function: a review of clinical and epidemiologic studies. J Neural Transm Suppl 53, 1-8.
126. Perkins AJ, Hendrie HC, Callahan CM, et al. (1999) Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 150, 37-44.
127. Schmidt R, Hayn M, Reinhart B, et al. (1998) Plasma antioxidants and cognitive performance in middle-aged and older adults: results of the Austrian Stroke Prevention study. J Am Geriatr Soc 46, 1407-1410. (Pubitemid 28511882)
128. Rosenblum WI, Nelson GH, Bei RA, et al. (1996) Vitamin E ameliorates adverse effects of endothelial injury in brain arterioles. Am J Physiol Heart Circul Physiol 40, H637-H642. (Pubitemid 126832380)
129. Leppälä JM, Virtamo J, Fogelholm R, et al. (2000) Controlled trial of α-tocopherol and β-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 20, 230-235. (Pubitemid 30048369)
130. Benson RT (1999) Vitamin E supplementation lowers risk for ischemic stroke. 51st Annual Meeting of the American Academy of Neurology. Toronto, Canada.
131. Devaraj S & Jialal I (2000) α Tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. Free Radic Biol Med 29, 790-792.
132. Hodis HN, Mack WJ, LaBree LD, et al. (2002) α-Tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106, 1453-1459.
133. Bunout D (2000) Therapeutic potential of vitamin E in heart disease. Expert Opin Investig Drugs 9, 2629-2635. (Pubitemid 30831314)
134. Dagenais GR, Marchioli R, Yusuf S, et al. (2000) β-Carotene, vitamin C, and vitamin E and cardiovascular diseases. Curr Cardiol Rep 2, 293-299.
135. Lonn E (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293, 1338-1347. (Pubitemid 40381486)
136. Miller ER III, Pastor-Barriuso R, Dalal D, et al. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Inter Med 142, 37-46. (Pubitemid 40066212)
137. Grzegorczyk K, Rutkowski M & Drozda R (2001) Vitamin C in treatment of certain cardiovascular diseases. Pol Merkur Lekarski 10, 122-125.
138. Foy CJ, Passmore AP, Vahidassr MD, et al. (1999) Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease. Q J Med 92, 39-45. (Pubitemid 29034099)
139. Frei, B. (ed.). (1994) Natural Antioxidants in Human Health and Disease. San Diego, CA: Academic Press.
140. Simon JA, Hudes ES & Browner WS (1998) Serum ascorbic acid and cardiovascular disease prevalence in U.S. adults. Epidemiolology 9, 316-321. (Pubitemid 28194242)
141. Ness AR, Powles JW & Khaw KT (1996) Vitamin C and cardiovascular disease: a systematic review. J Cardiovasc Risk 3, 513-521.
142. Sano M, Ernesto C, Thomas RG, et al. (1997) A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336, 1216-1222. (Pubitemid 27183651)
143. Padh H (1991) Vitamin C: newer insights into its biochemical functions. Nutr Rev 49, 65-70.
144. Sato K, Saito H & Katsuki H (1993) Synergism of tocopherol and ascorbate on the survival of cultured brain neurones. Neuroreport 4, 1179-1182. (Pubitemid 23278560)
145. Kurl S, Tuomainen TP, Laukkanen JA, et al. (2002) Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 33, 1568-1573. (Pubitemid 34619959)
146. Myint PK, Luben RN, Welch AA, et al. (2008) Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer-Norfolk prospective population study. Am J Clin Nutr 87, 64-69.
147. Joshipura KJ, Ascherio A, Manson JE, et al. (1999) Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 282, 1233-1239. (Pubitemid 29468494)
148. Cook NR, Albert CM, Gaziano JM, et al. (2007) A randomized factorial trial of vitamins C and E and b carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Int Med 167, 1610-1618. (Pubitemid 47280341)
149. Ullegaddi R, Powers HJ & Gariballa SE (2005) Antioxidant supplementation enhances antioxidant capacity and mitigates oxidative damage following acute ischaemic stroke. Eur J Clin Nutr 59, 1367-1373. (Pubitemid 43135151)
150. Ungvari Z, Buffenstein R, Austad SN, et al. (2008) Oxidative stress in vascular senescence: lessons from successfully aging species. Front Biosci 13, 5056-5070. (Pubitemid 351599658)
151. Allen CL & Bayraktutan U (2008) Risk factors for ischaemic stroke. Int J Stroke 3, 105-116.
152. Taffi R, Nanetti L, Mazzanti L, et al. (2008) Plasma levels of nitric oxide and stroke outcome. J Neurol 255, 94-98.
153. Ferretti G, Bacchetti T, Masciangelo S, et al. (2008) Lipid peroxidation in stroke patients. Clin Chem Lab Med 46, 113-117.
154. Seneş M, Kazan N, Coşkun Ö, et al. (2007) Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 44, 43-47. (Pubitemid 46168800)
155. Mariani E, Polidori MC, Cherubini A, et al. (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B 827, 65-75. (Pubitemid 41551598)
156. Cherubini A, Ruggiero C, Polidori MC, et al. (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39, 841-852. (Pubitemid 43316938)
157. Polidori MC, Frei B, Cherubini A, et al. (1998) Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 25, 561-567. (Pubitemid 28390312)
158. Cherubini A, Polidori MC, Bregnocchi M, et al. (2000) Antioxidant profile and early outcome in stroke patients. Stroke 31, 2295-2300. (Pubitemid 30740532)
159. Pratico D, Lee VMY, Trojanowski JQ, et al. (1998) Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 12, 1777-1783. (Pubitemid 28553673)
160. May JM, Qu ZC, Morrow JD, et al. (2000) Ascorbate-dependent protection of human erythrocytes against oxidant stress generated by extracellular diazobenzene sulfonate. Biochem Pharmacol 60, 47-53.
161. Kelly PJ, Morrow JD, Ning M, et al. (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39, 100-104.
162. Sánchez-Moreno C, Dashe JF, Scott T, et al. (2004) Decreased levels of plasma vitamin C and increased concentrations of inflammatory and oxidative stress markers after stroke. Stroke 35, 163-168. (Pubitemid 38057613)
163. Ozkul A, Akyol A, Yenisey C, et al. (2007) Oxidative stress in acute ischemic stroke. J Clin Neurosci 14, 1062-1066. (Pubitemid 47588935)
164. Bonithon-Kopp C, Coudray C, Berr C, et al. (1997) Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 65, 121-127. (Pubitemid 27020469)
165. Yoo JH & Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158, 425-430. (Pubitemid 32913653)
166. Iso H (2005) Homocysteine and increased risk of stroke. Cardiol Rev 22, 26-29.
167. Keli SO, Hertog MG, Feskens EJ, et al. (1996) Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med 156, 637-642.
168. Daviglus ML, Orencia AJ, Dyer AR, et al. (1997) Dietary vitamin C, β-carotene and 30-year risk of stroke: results from the Western Electric Study. Neuroepidemiology 16, 69-77.
169. Hirvonen T, Virtamo J, Korhonen P, et al. (2000) Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 31, 2301-2306. (Pubitemid 30740533)
170. Yokoyama T, Date C, Kokubo Y, et al. (2000) Serum vitamin C concentration was inversely associated with subsequent 20-year incidence of stroke in a Japanese rural community. The Shibata study. Stroke 31, 2287-2294. (Pubitemid 30740531)
171. Polidori MC, Mecocci P & Frei B (2001) Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke 32, 898-902. (Pubitemid 32285157)
172. Vokó Z, Hollander M, Hofman A, et al. (2003) Dietary antioxidants and the risk of ischemic stroke: The Rotterdam Study. Neurology 61, 1273-1275. (Pubitemid 37377554)
173. Benson RT, Jacobs B, Boden-Albala B, et al. (1999) Vitamin E intake: a primary preventive measure in stroke. Neurology 52, A146.
174. Vatassery GT, Bauer T & Dysken M (1999) High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr 70, 793-801. (Pubitemid 29512902)
175. Suter PM (2000) Effect of vitamin E, vitamin C, and β-carotene on stroke risk. Nutr Rev 58, 184-187.